Omeros announced preliminary results from additional critically Ill COVID-19 patients treated with narsoplimab
On May 28, 2021, Omeros announced preliminary results from the second cohort of critically ill COVID-19 patients treated…
Novartis and Molecular Partners announced start of EMPATHY clinical trial for ensovibep for treatment of COVID-19
On May 27, 2021, Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase…
Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19
On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…
Patient enrollment reached 90 percent in Innovation Pharmaceuticals phase 2 clinical trial of Brilacidin for COVID-19
On May 27, 2021, Innovation Pharmaceuticals announced that patient enrollment in the Companyﾒs 120-patient, Phase 2 clinical trial…
Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases
On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…
Sanofi and GSK initiated global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
On May 27, 2021, Sanofi and GlaxoSmithKline started enrolment in their Phase 3 clinical study to assess the…
NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut
On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…
Altimmune demonstrated strong neutralization of South African variant in preclinical study of intranasal AdCOVIDﾙ
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…
Henry Schein awarded Strategic National Stockpile contract for PPE storage and distribution
On May 26, 2021, Henry Schein announced the Company was awarded a $53.4 million contract from the U.S….
GSK and Vir Biotech announced sotrovimab (VIR-7831) received EUA from the US FDA for treatment of mild-to-moderate COVID-19 in high-risk adults and paediatric patients
On May 26, 2021, GlaxoSmithKline and Vir Biotechnology announced the U.S. Food and Drug Administration (FDA) granted an…
China facing serious experimental monkey shortage during the COVID-19 lockdown
On May 26, 2021, the National Center for Biotechnology Information announced a report that aimed to analyze the…
ImmunityBio expanded South African trials of T-cell-based COVID-19 vaccine candidate as ﾑUniversal Boostﾒ in vaccinated subjects
On May 25, 2021, ImmunityBio announced two South African studies to examine the potential for using its hAd5…
Moderna announced TeenCOVE study of COVID-19 vaccine in adolescents met primary endpoint
On May 25, 2021, Moderna announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents…
COVID-19 The Wave
Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…
NIH-funded study found higher dose of DHA associated with lower early preterm birth rate
On May 24, 2021, scientists reported that women taking 1,000 mg of docosohexanoic acid (DHA) daily in the…
Disease | Life Science News | Vaccine | WHO
WHO and Switzerland launched global BioHub for pathogen storage, sharing and analysis
On May 24, 2021, the World Health Organization (WHO) and the Swiss Confederation signed a Memorandum of Understanding…
Health Canada approved Quidel’s Sofia’ SARS antigen FIA test for screening asymptomatic populations
On May 24, 2021, Quidel announced that its Sofia’ SARS Antigen FIA was the first rapid antigen test…
Moderna and Aldevron announced expanded partnership for mRNA vaccine and therapeutic pipeline
On May 24, 2021, Moderna and Aldevron announced their expanded collaboration in support of the Moderna COVID-19 Vaccine…
Labcorp study suggested COVID-19 antibodies remain at least 10 months after infection
On May 24, 2021, LabCorp reported that nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2…
Study initiated exploring coadministration of 20-valent pneumococcal conjugate vaccine with third dose of Pfizer-BioNTech COVID-19 vaccine
On May 24, 2021, Pfizer announced that the first enrolled subjects had received their immunizations as part of…
Moderna and Samsung Biologics announced agreement for manufacturing of Moderna’s COVID-19 vaccine
On May 22, 2021, Moderna and Samsung Biologics announced a Manufacturing Services and Supply Agreement in which Samsung…
Novavax announced MOU to explore expansion of COVID-19 vaccine activities in South Korea
On May 22, 2021, Novavax announced the signing of a non-binding memorandum of understanding (MoU) with the Ministry…
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved first targeted therapy for subset of non-small cell lung cancer
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
G20 leaders boosted support of the Access to COVID-19 Tools Accelerator
On May 21, 2021, world leaders the Global Health Summit adopted an agenda to overcome the COVID-19 pandemic,…
Japan’s Ministry of Health, Labour and Welfare approved Moderna’s COVID-19 vaccine
On May 21, 2021, Moderna announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan granted…
Ministry of Food and Drug Safety of South Korea authorized Moderna’s COVID-19 vaccine
On May 21, 2021, Moderna announced that the Ministry of Food and Drug Safety of South Korea (MFDS)…
Complete trial results of Novavax COVID-19 investigational vaccine posted to preprint server medRxiv
On May 21, 2021, Novavax announced that the full results from the Phase 3, randomized, observer-blinded, placebo-controlled trial…
Novavax announced participation in mix-and-match COVID-19 vaccine booster trial in the United Kingdom
On May 21, 2021, Novavax announced participation in a mix-and-match (vaccine interchangeability) COVID-19 vaccine booster trial that led…
EMA issued positive scientific opinion on GSK and Vir Biotechnologyﾒs sotrovimab for the early treatment of COVID-19
On May 21, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agencyﾒs (EMA) Committee for Human…